The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study

BACKGROUND: The burden of COVID-19 in patients with bullous pemphigoid (BP) and pemphigus is yet to be evaluated. OBJECTIVE: To assess the risks of COVID-19 and COVID-19-associated hospitalization and mortality in patients with BP and pemphigus and to delineate determinants of severe COVID-19 illnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kridin, Khalaf, Schonmann, Yochai, Weinstein, Orly, Schmidt, Enno, Ludwig, Ralf J., Cohen, Arnon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968167/
https://www.ncbi.nlm.nih.gov/pubmed/33744354
http://dx.doi.org/10.1016/j.jaad.2021.02.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968167/
https://www.ncbi.nlm.nih.gov/pubmed/33744354
http://dx.doi.org/10.1016/j.jaad.2021.02.087

Ejemplares similares